| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |